Bruker [BRKR] vs Penumbra [PEN] Detailed Stock Comparison
Bruker
NASDAQ
Loading...
Penumbra
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Bruker wins in 6 metrics, Penumbra wins in 13 metrics, with 0 ties. Penumbra appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bruker | Penumbra | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 58.52 | 63.62 | Bruker |
| Price-to-Book Ratio | 2.56 | 7.22 | Bruker |
| Debt-to-Equity Ratio | 132.75 | 17.04 | Penumbra |
| PEG Ratio | 11.23 | 63.62 | Bruker |
| EV/EBITDA | 12.66 | 43.56 | Bruker |
| Profit Margin (TTM) | 2.31% | 11.54% | Penumbra |
| Operating Margin (TTM) | 3.61% | 21.87% | Penumbra |
| EBITDA Margin (TTM) | 3.61% | 21.87% | Penumbra |
| Return on Equity | 4.07% | 12.03% | Penumbra |
| Return on Assets (TTM) | 3.55% | 7.51% | Penumbra |
| Free Cash Flow (TTM) | $136.00M | $147.30M | Penumbra |
| 1-Year Return | -50.92% | 41.44% | Penumbra |
| Price-to-Sales Ratio (TTM) | 1.37 | 7.33 | Bruker |
| Enterprise Value | $7.06B | $9.14B | Penumbra |
| EV/Revenue Ratio | 2.05 | 7.14 | Bruker |
| Gross Profit Margin (TTM) | 44.88% | 65.99% | Penumbra |
| Revenue per Share (TTM) | $23 | $33 | Penumbra |
| Earnings per Share (Diluted) | $0.52 | $3.78 | Penumbra |
| Beta (Stock Volatility) | 1.16 | 0.40 | Penumbra |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Bruker vs Penumbra Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bruker | -2.34% | -19.90% | -28.16% | -24.88% | -40.49% | -48.26% |
| Penumbra | -0.10% | -1.04% | -2.95% | -16.71% | -7.88% | 0.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bruker | -50.92% | -50.77% | -29.45% | 51.09% | 133.72% | 644.01% |
| Penumbra | 41.44% | 39.80% | 2.95% | 482.30% | 482.30% | 482.30% |
Performance & Financial Health Analysis: Bruker vs Penumbra
| Metric | BRKR | PEN |
|---|---|---|
| Market Information | ||
| Market Cap | $4.73B | $9.39B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 4,297,610 | 606,920 |
| 90 Day Avg. Volume | 3,660,770 | 478,647 |
| Last Close | $30.43 | $240.49 |
| 52 Week Range | $30.19 - $72.94 | $164.42 - $310.00 |
| % from 52W High | -58.28% | -22.42% |
| All-Time High | $94.86 (Mar 18, 2024) | $348.67 (Jun 26, 2023) |
| % from All-Time High | -67.92% | -31.03% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.00% | 0.13% |
| Quarterly Earnings Growth | 0.00% | 0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.12% |
| Operating Margin (TTM) | 0.04% | 0.22% |
| Return on Equity (TTM) | 0.04% | 0.12% |
| Debt to Equity (MRQ) | 132.75 | 17.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $11.89 | $33.32 |
| Cash per Share (MRQ) | $0.65 | $10.93 |
| Operating Cash Flow (TTM) | $165.90M | $36.77M |
| Levered Free Cash Flow (TTM) | $223.20M | $224.96M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Bruker vs Penumbra
| Metric | BRKR | PEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 58.52 | 63.62 |
| Forward P/E | 11.23 | 63.62 |
| PEG Ratio | 11.23 | 63.62 |
| Price to Sales (TTM) | 1.37 | 7.33 |
| Price to Book (MRQ) | 2.56 | 7.22 |
| Market Capitalization | ||
| Market Capitalization | $4.73B | $9.39B |
| Enterprise Value | $7.06B | $9.14B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.05 | 7.14 |
| Enterprise to EBITDA | 12.66 | 43.56 |
| Risk & Other Metrics | ||
| Beta | 1.16 | 0.40 |
| Book Value per Share (MRQ) | $11.89 | $33.32 |
Financial Statements Comparison: Bruker vs Penumbra
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BRKR | PEN |
|---|---|---|
| Revenue/Sales | $801.40M | $324.14M |
| Cost of Goods Sold | $410.20M | $108.26M |
| Gross Profit | $391.20M | $215.88M |
| Research & Development | $97.10M | $22.08M |
| Operating Income (EBIT) | $65.70M | $40.35M |
| EBITDA | $118.60M | $49.20M |
| Pre-Tax Income | $25.10M | $43.86M |
| Income Tax | $8.70M | $4.64M |
| Net Income (Profit) | $16.80M | $39.22M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BRKR | PEN |
|---|---|---|
| Cash & Equivalents | $184.20M | $376.05M |
| Total Current Assets | $2.11B | $999.71M |
| Total Current Liabilities | $1.34B | $158.63M |
| Long-Term Debt | $2.08B | $205.85M |
| Total Shareholders Equity | $1.85B | $1.21B |
| Retained Earnings | $2.42B | $99.23M |
| Property, Plant & Equipment | N/A | $274.92M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BRKR | PEN |
|---|---|---|
| Operating Cash Flow | $55.70M | $46.01M |
| Capital Expenditures | $-26.00M | $-13.47M |
| Free Cash Flow | $39.00M | $35.50M |
| Debt Repayment | $-175.60M | $-613,000 |
| Common Stock Repurchase | $-10.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BRKR | PEN |
|---|---|---|
| Shares Short | 9.45M | 1.83M |
| Short Ratio | 3.44 | 4.26 |
| Short % of Float | 0.13% | 0.07% |
| Average Daily Volume (10 Day) | 4,297,610 | 606,920 |
| Average Daily Volume (90 Day) | 3,660,770 | 478,647 |
| Shares Outstanding | 151.68M | 38.49M |
| Float Shares | 103.13M | 37.66M |
| % Held by Insiders | 0.32% | 0.04% |
| % Held by Institutions | 0.83% | 0.92% |
Dividend Analysis & Yield Comparison: Bruker vs Penumbra
| Metric | BRKR | PEN |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |